- Home
- BUUU vs CNTB Comparison
BUUU vs CNTB Comparison
Compare BUUU & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BUUU | CNTB |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | Hong Kong | United States |
| Employees | 16 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.8M | 128.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BUUU | CNTB |
|---|---|---|
| Price | $16.30 | $2.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 21.4K | ★ 116.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $26,033,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24,617.69 |
| P/E Ratio | $347.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.97 | $0.51 |
| 52 Week High | $20.76 | $3.28 |
Technical Indicators
Market Signals| Indicator | BUUU | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | 62.63 |
| Support Level | $6.84 | $2.30 |
| Resistance Level | $19.73 | $3.23 |
| Average True Range (ATR) | 1.54 | 0.18 |
| MACD | -0.21 | 0.03 |
| Stochastic Oscillator | 44.44 | 92.17 |
Price Performance
Historical ComparisonAbout BUUU BUUU Group Limited Class A Ordinary Share
BUUU Group Ltd provides comprehensive meetings, incentives, conferences, and exhibitions (MICE) solutions focused on event management and stage production. Its event management team offers creative planning, project management, and on-site supervision for a wide range of cultural, artistic, recreational, and corporate events, working closely with clients and partners. The stage production team creates immersive event experiences by managing lighting, audio-visual systems, stage performance elements, and venue decorations, overseeing the entire production process. Event management generates the majority of revenue.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.